Excel Medical Achieves Recognition Among Fastest-Growing Firms

Excel Medical Honored as One of America's Top Companies
Excel Medical proudly announces its remarkable achievement of being included in the prestigious Inc. 5000 list, highlighting the fastest-growing private companies in America. This recognition marks the second consecutive year that the innovative healthcare provider has earned this distinction. Excel Medical stands out as the sole hormone replacement therapy provider to achieve this honor two years in a row, illustrating its commitment to excellence in the healthcare sector.
A Testament to Growth and Innovation
Craig Larsen, CEO of Excel Medical, expressed his excitement about this recognition, stating, "Earning a place on the Inc. 5000 list for the second consecutive year is an incredible milestone for our team and our members. We've built this company by staying true to our mission of transforming healthcare from reactive to proactive, proving you don't need outside funding to scale a business to nearly $100 million in annual revenue." His words resonate with the dedication and trust from more than 100,000 members served over the years, showcasing the hard work of their clinical and leadership teams.
Exceptional Performance During Economic Challenges
The 2025 honorees have demonstrated extraordinary growth amid economic challenges, such as inflation and fluctuating labor markets. The median three-year revenue growth rate for the top 500 companies reached an impressive 1,552 percent, collectively contributing over 48,678 jobs to the U.S. economy. This growth is a remarkable achievement, particularly in today's uncertain economic environment, where businesses have had to navigate various obstacles.
Proactive Healthcare Transformation
Since its founding, Excel Medical has consistently led the pack in telemedicine hormone replacement therapy. Through its proprietary treatment protocol known as The Excel Advantage™, the company has set new benchmarks for treatment approaches, emphasizing preventive rather than reactive care. This unique focus on the health and well-being of patients has allowed Excel Medical, as well as its affiliated services, Male Excel and Fem Excel, to expand and thrive in a competitive market.
Celebrating Entrepreneurial Excellence
The recognition from Inc. is not just a badge of honor but also a testament to the tenacity and clarity of vision that drives these businesses forward. Mike Hofman, editor-in-chief of Inc., remarked on the remarkable achievement of companies like Excel Medical, noting their ability to thrive amid rising costs and shifting global dynamics. The stories of these businesses, including their innovative approaches and dedication to their missions, are a potent reminder of the entrepreneurial spirit that fuels the U.S. economy.
As a leading provider in hormone replacement therapy, Excel Medical stands poised to redefine healthcare through proactive hormone therapy. Their mission focuses on personalized care, prioritizing patient needs and optimizing hormone therapy's benefits for both men and women. The substantial growth and ongoing innovation in this field showcase Excel Medical's commitment to improving health outcomes for individuals across the country.
Building a Legacy of Trust
Excel Medical continues to build on its legacy, providing unique and tailored solutions for hormone optimization that genuinely enhance the quality of life. Their success in transitioning from an in-person practice to a leading national telehealth provider demonstrates how the company has adapted to meet the changing needs of its members efficiently. This evolution speaks volumes about their dedication to patient care and their innovative model of healthcare.
For further insights into this incredible achievement and more about what makes Excel Medical a leader in its field, follow their journey as they continue to grow and make a meaningful impact in healthcare.
Frequently Asked Questions
What is the Inc. 5000 list?
The Inc. 5000 list is an annual ranking of the fastest-growing private companies in the United States, recognizing innovation and growth in various industries.
How does Excel Medical differentiate itself?
Excel Medical stands out as a pioneer in telemedicine hormone replacement therapy, focusing on proactive healthcare through its proprietary treatment protocol.
What does being on the Inc. 5000 list mean for Excel Medical?
This recognition reflects Excel Medical's significant growth and the trust it has built with over 100,000 members in its dedication to transforming healthcare.
Who is the CEO of Excel Medical?
Craig Larsen is the CEO of Excel Medical, and he has been instrumental in the company's growth and mission to redefine healthcare through proactive therapy.
What impact does Excel Medical have on the economy?
Excel Medical contributes to the economy by creating jobs and demonstrating significant revenue growth, reflecting its role as a leading health provider in a competitive field.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.